Successful treatment of γ-heavy-chain disease with rituximab and fludarabine

Acta Haematologica

Volumn 128, Issue 3, 2012, Pages 139-143

  Inoue, Daichi ^a,b   Matsushita, Akiko ^a   Kiuchi, Mineyo ^a   Takiuchi, Yoko ^a   Nagano, Seiji ^a   Arima, Hiroshi ^a   Mori, Minako ^a   Tabata, Sumie ^a   Yamashiro, Akiko ^a   Maruoka, Hayato ^a   Oita, Tatsuo ^a   Imai, Yukihiro ^a   Takahashi, Takayuki ^a  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Heavy chain disease; Fludarabine; Lymphoplasmacytic lymphoma; Rituximab

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; FLUDARABINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M KAPPA CHAIN; RITUXIMAB; UNCLASSIFIED DRUG;

AGED; ARTICLE; BONE MARROW EXAMINATION; BONE MARROW HYPOPLASIA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; HEAVY CHAIN DISEASE; HEMATOPOIESIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOELECTROPHORESIS; JAPANESE; LYMPHOCYTE; LYMPHOMA CELL; MALE; PANCYTOPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ROCKET IMMUNOSELECTION ASSAY; TREATMENT OUTCOME; WALDENSTROEM MACROGLOBULINEMIA;

AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; HEAVY CHAIN DISEASE; HUMANS; LYMPHOMA, B-CELL; MALE; VIDARABINE; WALDENSTROM MACROGLOBULINEMIA;

EID: 84864794164     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000339097     Document Type: Article

References (16)

1. Fermand JP, Brouet JC, Danon F, Seligmann M: Gamma heavy chain 'disease': heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature. Medicine (Baltimore) 1989; 68: 321-335.
2. Wahner-Roedler DL, Witzig TE, Loehrer LL, Kyle RA: Gamma-heavy chain disease: review of 23 cases. Medicine (Baltimore) 2003; 82: 236-250.
3. Witzig TE, Wahner-Roedler DL: Heavy chain disease. Curr Treat Options Oncol 2002; 3: 247-254.
4. Wester SM, Banks PM, Li CY: The histopathology of gamma heavy-chain disease. Am J Clin Pathol 1982; 78: 427-436.
5. van Dongen JJ, Langerak AW, Brüggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, García-Sanz R, van Krieken JH, Droese J, González D, Bastard C, White HE, Spaargaren M, González M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA: Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the Biomed-2 concerted action BMH4-CT98-3936. Leukemia 2003; 17: 2257-2317.
6. Gale DS, Versey JM, Hobbs JR: Rocket immunoselection for detection of heavy-chain diseases. Clin Chem 1974; 20: 1292-1294.
7. Yanai M, Maeda A, Watanabe N, Sugimoto N, Matsushita A, Nagai K, Oida T, Takahashi T: Successful treatment of mu-heavy chain disease with fludarabine monophosphate: a case report. Int J Hematol 2004; 79: 174-177.
8. Chan MH, Cheung RC, Lam CW: Test and teach. Laboratory characterisation of paraproteins. Heavy chain disease. Pathology 2001; 33: 379-381.
9. Wahner-Roedler DL, Kyle RA: Heavy chain diseases. Best Pract Res Clin Haematol 2005; 18: 729-746.
10. Munshi NC, Digumarthy S, Rahemtullah A: Case records of the Massachusetts General Hospital. Case 13-2008. A 46-year-old man with rheumatoid arthritis and lymphadenopathy. N Engl J Med 2008; 358: 1838-1848.
11. Kyle RA, Robinson RA, Katzmann JA: The clinical aspects of biclonal gammopathies. Review of 57 cases. Am J Med 1981; 71: 999-1008.
12. Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP: Diagnosis and management of Waldenstrom's macroglobulinemia. J Clin Oncol 2005; 23: 1564-1577.
13. Vijay A, Gertz MA: Waldenström macroglobulinemia. Blood 2007; 109: 5096-5103.
14. Takano H, Nagata K, Mikoshiba M, Nakane M, Kato A, Hamaguchi H: Combination of rituximab and chemotherapy showing antitumor effect in gamma heavy chain disease expressing cd20. Am J Hematol 2008; 83: 938-939.
15. Del Giudice I, Matutes E, Osuji N, Parry-Jones N, Swansbury J, Catovsky D: Delayed response to fludarabine in lymphoplasmacytic lymphoma/ Waldenström's macroglobulinemia. Haematologica 2005; 90: 268-270.
16. Wendtner CM, Schmitt B, Bergmann M, Röhnisch T, Buhmann R, Hallek M: New aspects on the pathogenesis, diagnostic procedures, and therapeutic management of chronic lymphocytic leukemia. Int J Hematol 2001; 73: 32-38.